Reconsidering Claims of Equivalence Between Oral and Intravenous Antibiotic Therapy for Infective Endocarditis: A Critical Appraisal of the Evidence
Open Forum Infectious Diseases · 31.10.2026 · 13 (11)
DOI: 10.1093/ofid/ofag694 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 26.10.2026. Verfasst von Dawd S Siraj und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, University of Wisconsin, Madison, Madison, Wisconsin, USA. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, University of Wisconsin, Madison, Madison, Wisconsin, USA.
- Office of Biostatistics/Epidemiology, Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.
ORCID-Profile: Dawd S Siraj, Fauzia Hollnagel
Zitieren
APA
Siraj, D. S., & Hollnagel, F. (2026). Reconsidering Claims of Equivalence Between Oral and Intravenous Antibiotic Therapy for Infective Endocarditis: A Critical Appraisal of the Evidence. Open Forum Infectious Diseases, 13(11). https://doi.org/10.1093/ofid/ofag694
Vancouver
Siraj DS, Hollnagel F. Reconsidering Claims of Equivalence Between Oral and Intravenous Antibiotic Therapy for Infective Endocarditis: A Critical Appraisal of the Evidence. Open Forum Infectious Diseases. 2026;13(11). doi:10.1093/ofid/ofag694
BibTeX
@article{Siraj2026,
author = {Siraj, Dawd S and Hollnagel, Fauzia},
title = {Reconsidering Claims of Equivalence Between Oral and Intravenous Antibiotic Therapy for Infective Endocarditis: A Critical Appraisal of the Evidence},
journal = {Open Forum Infectious Diseases},
year = {2026},
volume = {13},
number = {11},
doi = {10.1093/ofid/ofag694}
}
EUVIMED